Cargando…

Reactive resistance to anti-angiogenic drugs

Detalles Bibliográficos
Autores principales:	Bousquet, Guilhem, Janin, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468305/ https://www.ncbi.nlm.nih.gov/pubmed/26022438

Ejemplares similares

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

A Boom in Nanotechnologies for a High Level of Precision Medicine
por: Angeli, Eurydice, et al.
Publicado: (2023)

Drug resistance-related sunitinib sequestration in autophagolysosomes of endothelial cells
por: Wu, Shuang, et al.
Publicado: (2019)

TP53 Status and Response to Treatment in Breast Cancers
por: Varna, Mariana, et al.
Publicado: (2011)

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19
por: Omarjee, Loukman, et al.
Publicado: (2020)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma
por: Wang, Li, et al.
Publicado: (2010)

Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
por: Montemagno, Christopher, et al.
Publicado: (2020)

Anti-Angiogenic Activity of Drugs in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2023)

A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report
por: Hamdan, Diaddin, et al.
Publicado: (2015)

Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
por: Osawa, Tsuyoshi, et al.
Publicado: (2013)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
por: Barillari, Giovanni
Publicado: (2020)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
por: Chimote, Geetanjali, et al.
Publicado: (2014)

HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
por: Hochster, H S
Publicado: (2013)

Cell Death Induced on Cell Cultures and Nude Mouse Skin by Non-Thermal, Nanosecond-Pulsed Generated Plasma
por: Duval, Arnaud, et al.
Publicado: (2013)

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
por: Nunes, Toni, et al.
Publicado: (2019)

Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
por: Sturrock, M., et al.
Publicado: (2018)

Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action
por: Quayle, Lewis A., et al.
Publicado: (2017)

Correlation of anti-tumour drug resistance with epigenetic regulation
por: Hayashi, Takuma, et al.
Publicado: (2020)

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
por: Pisarsky, Laura, et al.
Publicado: (2016)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
por: Schiffmann, Lars M., et al.
Publicado: (2022)

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
por: Jeon, Hanwool, et al.
Publicado: (2023)

Extracellular vesicles in tumor angiogenesis and resistance to anti‐angiogenic therapy
por: Ye, Zi‐Wu, et al.
Publicado: (2023)

Deregulation of the circadian clock machinery: A novel biomarker for anti-angiogenic drug resistance in colorectal cancer
por: Della-Morte, David
Publicado: (2019)

Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

Angiogenic Dreaded Killer: Cholesterol Crystal Embolization
por: Kuwatani, Masaki, et al.
Publicado: (2020)

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs
por: Decazes, Pierre, et al.
Publicado: (2023)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta
por: Uyanıkoğlu, Hacer, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2gq4o6r4uih4artkh5ucmsdh5m